Aphena’s Three-Year, $20M Tennessee Expansion Now Complete
04 Nov 2022 //
BUSINESSWIRE
Aphena Completes $20M Tennessee Expansion
27 Oct 2022 //
CONTRACTPHARMA
CMO Becoming a Powerhouse With Expansions and New Facilities
07 Dec 2021 //
CONTRACTPHARMA
Aphena Announces the Launch of Its New Third-Party Logistics Division
10 Aug 2021 //
BUSINESSWIRE
Aphena’s $21M Cookeville Expansion Nears Completion
26 Jan 2021 //
CONTRACTPHARMA
Aphena Adds Cold Chain Storage, Biologics Packaging and Distribution
11 Nov 2020 //
CONTRACT PHARMA
Releviate Inks Exclusive License for Human Monoclonal Antibodies
27 Oct 2020 //
BUSINESSWIRE
Tennessee packager drops $21M into `state-of-the-art` facility
01 Oct 2020 //
FIERCE PHARMA
Aphena Pharma Solutions Invests $7M for Expansion
16 May 2019 //
CONTRACT PHARMA
Valsartan products not currently recalled - Updated November 27, 2018
28 Nov 2018 //
FDA
Valsartan products not currently recalled - Updated August 8, 2018
09 Aug 2018 //
FDA